Utility of [18f]FDG Positron Emission Tomography for Predicting Histopathologic Response in Esophageal Carcinoma Following Chemoradiation
Andrea Arnett(Mayo Clinic), Christopher L. Hallemeier(Mayo Clinic in Arizona), Ethel MacIntosh(Mayo Clinic in Arizona), Michael G. Haddock(Mayo Clinic in Arizona), M.A. Neben-Wittich(Mayo Clinic), K. Robert Shen, Kenneth W. Merrell(Mayo Clinic), Karthik Ravi(Mayo Clinic)
International Journal of Radiation Oncology*Biology*Physics
October 1, 2016
Cited by 1
Related Papers
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer
|Annals of Surgery|2019|445
Adjuvant Radiotherapy and Chemotherapy for Pancreatic Carcinoma: The Mayo Clinic Experience (1975-2005)
|Journal of Clinical Oncology|2008|270
Oesophageal cancer
|The Lancet|2024|265